LENZ Therapeutics Inc (LENZ) financials · rev $19.1M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
LENZ Therapeutics Inc (LENZ) rev $19.1M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $19.1M | N/A |
| Cost of Revenue | $418.0K | N/A |
| Gross Profit | $18.7M | N/A |
| Operating Income | -$91.1M | -$58.6M |
| Net Income | -$82.1M | -$49.8M |
| EPS (Diluted) | -$2.85 | -$2.34 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $305.9M | $215.3M |
| Current Assets | $301.4M | $211.9M |
| Cash & Equivalents | $25.2M | $20.2M |
| Inventory | $2.94M | $0 |
| PP&E | $1.19M | $651.0K |
| Total Liabilities | $21.5M | $11.2M |
| Current Liabilities | $21.2M | $10.4M |
| Shareholders' Equity | $284.3M | $204.1M |
| Retained Earnings | -$227.1M | -$145.0M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$69.2M | -$59.4M |
| CapEx | $827.0K | $468.0K |
| Investing Cash Flow | -$75.7M | -$154.5M |
| Financing Cash Flow | $149.7M | $199.0M |
| Net Change in Cash | $4.91M | -$14.9M |
| Free Cash Flow | -$70.0M | -$59.9M |
FAQ
What is LENZ P/E and revenue?
LENZ Therapeutics Inc (LENZ) rev $19.1M.
What is LENZ revenue?
LENZ Therapeutics Inc last cached revenue is $19.1M (FY2025).
Is LENZ profitable?
LENZ Therapeutics Inc last cached net income is -$82.1M (FY2025).
What are LENZ total assets?
LENZ Therapeutics Inc last cached total assets are $305.9M (FY2025).
What is LENZ free cash flow?
LENZ Therapeutics Inc last cached free cash flow is -$70.0M (FY2025).
Not investment advice. Cached statements, not a live tape.